• 1. Catalyst- and solvent-free conditions as an environmentally benign approach to 4-aryl-3-cyano-hexahydro-4H-1,2-benzoxazine-2-oxides
  Gianfranco Bellachioma,Luca Castrica,Francesco Fringuelli,Ferdinando Pizzo,Luigi Vaccaro Green Chem. 2008 10 327
• 2. Photoinduced electron transfer from enol silyl ethers to quinone. Part 1. Pronounced effects of solvent polarity and added salt on the formation of α-enones
  T. Michael Bockman,D. Shukla,Jay K. Kochi J. Chem. Soc. Perkin Trans. 2 1996 1623
• 3. Triterpenoid total synthesis. Part 5.1 Synthetic disproof of the triterpene structure proposed for naurol A, a cytotoxic metabolite of a Pacific sponge
  Dai Nozawa,Hirosato Takikawa,Kenji Mori J. Chem. Soc. Perkin Trans. 1 2000 2043
• 4. Dehydrosilylation versus α-coupling in the electron-transfer of enol silyl ethers to quinones. Strong solvent effect on photogenerated ion pairs
  T. Michael Bockman,Serge Perrier,Jay K. Kochi J. Chem. Soc. Perkin Trans. 2 1993 595
• 5. Addition of carbon nucleophiles to hemiaminals promoted by a Lewis acidic polyoxotungstate
  Wen-Jing Xuan,Candice Botuha,Bernold Hasenknopf,Serge Thorimbert Org. Chem. Front. 2014 1 1091

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Organoheterosilanes
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Introduction to 1-(Trimethylsiloxy)cyclohexene (CAS No. 6651-36-1)

1-(Trimethylsiloxy)cyclohexene, identified by the Chemical Abstracts Service Number (CAS No.) 6651-36-1, is a significant compound in the field of organic synthesis and pharmaceutical chemistry. This molecule, featuring a cyclohexene backbone modified with a trimethylsiloxy group, has garnered attention due to its versatile applications in synthetic transformations and potential utility in drug development.

The trimethylsiloxy (TMSO) moiety is a crucial functional group in modern synthetic chemistry, known for its stability and reactivity under various conditions. The presence of this group in 1-(Trimethylsiloxy)cyclohexene enhances its utility as an intermediate in the synthesis of more complex molecules. The cyclohexene ring, a common structural motif in natural products and pharmaceuticals, provides a stable framework for further functionalization.

In recent years, 1-(Trimethylsiloxy)cyclohexene has been explored in the development of novel synthetic methodologies. One notable application is its use as a precursor in the synthesis of enantiomerically pure compounds, which are highly sought after in pharmaceutical research. The siloxy group facilitates asymmetric transformations, enabling the construction of chiral centers with high enantioselectivity. This has opened new avenues for the preparation of biologically active molecules with improved pharmacological properties.

The compound's reactivity also makes it valuable in cross-coupling reactions, such as Suzuki-Miyaura and Heck couplings, which are fundamental to constructing complex organic frameworks. The silicon-based functionality allows for easy manipulation under mild conditions, often avoiding harsh reagents or high temperatures that might degrade sensitive intermediates.

Recent studies have highlighted the role of 1-(Trimethylsiloxy)cyclohexene in polymer chemistry. Its incorporation into polymer backbones can enhance material properties such as thermal stability and flexibility. Researchers have demonstrated its use in the synthesis of siloxane-based polymers, which exhibit unique mechanical and chemical resistance characteristics. These materials are particularly relevant in industries requiring durable and high-performance polymers.

Another emerging area of interest is the application of 1-(Trimethylsiloxy)cyclohexene in medicinal chemistry. The compound's structural features make it a promising candidate for further derivatization into bioactive molecules. For instance, modifications at the cyclohexene ring or the siloxy group can lead to novel pharmacophores with potential therapeutic effects. Current research is exploring its role in developing treatments for neurological disorders, where precise molecular architecture is critical for efficacy.

The synthesis of 1-(Trimethylsiloxy)cyclohexene itself is an intriguing aspect of organic chemistry. Traditional methods involve the reaction of cyclohexene with trimethylchlorosilane in the presence of a base catalyst. However, recent advances have introduced more efficient and sustainable synthetic routes. For example, photochemical activation has been employed to achieve selective functionalization, reducing byproduct formation and improving overall yields.

In conclusion, 1-(Trimethylsiloxy)cyclohexene (CAS No. 6651-36-1) represents a versatile building block with broad applications across multiple disciplines. Its unique structural features and reactivity make it indispensable in synthetic chemistry, pharmaceutical research, and materials science. As research continues to uncover new methodologies and applications, this compound is poised to play an even greater role in advancing scientific and industrial innovation.

• 50338-42-6(Silane, (1-cycloocten-1-yloxy)trimethyl-)
• 72551-32-7(Silane, trimethyl[(1-propylidenedecyl)oxy]-, (Z)- (9CI))
• 51584-36-2(Silane, (1-cyclododecen-1-yloxy)trimethyl-)
• 89683-93-2(Silane, trimethyl[(1-pentyl-1-hexenyl)oxy]-, (E)- (9CI))
• 64682-31-1(Silane, [[(1Z)-1-butyl-1-penten-1-yl]oxy]trimethyl-)
• 74173-15-2([(Cyclodec-1-en-1-yl)oxy](trimethyl)silane)
• 55314-46-0(Cyclododecene, 1-[(trimethylsilyl)oxy]-, (1Z)-)
• 55314-44-8(Silane, (1-cyclododecen-1-yloxy)trimethyl-, (E)-)
• 72551-33-8(Silane, [(1-hexylidenedecyl)oxy]trimethyl-, (Z)-)
• 72551-29-2(Silane, trimethyl[(1-propyl-1-heptenyl)oxy]-, (Z)- (9CI))